| Transcription termination by the eukaryotic RNA polymerase III AG Arimbasseri, K Rijal, RJ Maraia Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms 1829 (3-4 …, 2013 | 157 | 2013 |
| Comparative overview of RNA polymerase II and III transcription cycles, with focus on RNA polymerase III termination and reinitiation AG Arimbasseri, K Rijal, RJ Maraia Transcription 5 (1), e27369, 2014 | 105 | 2014 |
| Uremic solute-aryl hydrocarbon receptor-tissue factor axis associates with thrombosis after vascular injury in humans VB Kolachalama, M Shashar, F Alousi, S Shivanna, K Rijal, ... Journal of the American Society of Nephrology 29 (3), 1063-1072, 2018 | 103 | 2018 |
| Evolving specificity of tRNA 3-methyl-cytidine-32 (m3C32) modification: a subset of tRNAsSer requires N6-isopentenylation of A37 AG Arimbasseri, J Iben, FY Wei, K Rijal, K Tomizawa, M Hafner, ... Rna 22 (9), 1400-1410, 2016 | 86 | 2016 |
| Targeting STUB1–tissue factor axis normalizes hyperthrombotic uremic phenotype without increasing bleeding risk M Shashar, ME Belghasem, S Matsuura, J Walker, S Richards, F Alousi, ... Science translational medicine 9 (417), eaam8475, 2017 | 51 | 2017 |
| A new role for cisplatin: probing ribosomal RNA structure K Rijal, CS Chow Chemical communications, 2008 | 47 | 2008 |
| RNA polymerase III mutants in TFIIFα-like C37 that cause terminator readthrough with no decrease in transcription output K Rijal, RJ Maraia Nucleic acids research 41 (1), 139-155, 2013 | 43 | 2013 |
| Amino acid-linked platinum (II) analogues have altered specificity for RNA compared to cisplatin K Rijal, X Bao, CS Chow Chemical Communications 50 (30), 3918-3920, 2014 | 38 | 2014 |
| Lack of tRNA-i6A modification causes mitochondrial-like metabolic deficiency in S. pombe by limiting activity of cytosolic tRNATyr, not mito-tRNA TN Lamichhane, AG Arimbasseri, K Rijal, JR Iben, FY Wei, K Tomizawa, ... Rna 22 (4), 583-596, 2016 | 37 | 2016 |
| Point mutations in the Rpb9-homologous domain of Rpc11 that impair transcription termination by RNA polymerase III JR Iben, JK Mazeika, S Hasson, K Rijal, AG Arimbasseri, AN Russo, ... Nucleic acids research 39 (14), 6100-6113, 2011 | 37 | 2011 |
| A mass spectrometric method for quantification of tryptophan-derived uremic solutes in human serum A Zhang, K Rijal, SK Ng, K Ravid, V Chitalia Journal of biological methods 4 (3), 2017 | 22 | 2017 |
| A methods review on use of nonsense suppression to study 3′ end formation and other aspects of tRNA biogenesis K Rijal, RJ Maraia, AG Arimbasseri Gene 556 (1), 35-50, 2015 | 19 | 2015 |
| Active Center Control of Termination by RNA Polymerase III and tRNA Gene Transcription Levels In Vivo K Rijal, RJ Maraia PLoS genetics 12 (8), e1006253, 2016 | 18 | 2016 |
| A transcriptional specialist resolved RJ Maraia, K Rijal Nature 528 (7581), 204-205, 2015 | 15 | 2015 |
| Exploring potential drug target sites in the ribosome using cisplatin and its analogues K Rijal Wayne State University, 2011 | 3 | 2011 |
| Amino acid-linked platinum (II) analogues have altered RNA adduct profiles compared to cisplatin CS Chow, X Bao, C He, B Kimutai, K Rijal, MT Rodgers JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY 22, S170-S170, 2017 | | 2017 |
| Synthesis, characterization, and RNA reactivity of cisplatin analogs X Bao, K Rijal, J Jiang, MT Rodgers, CS Chow ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 247, 2014 | | 2014 |
| The ribosome: versatile drug target site K Rijal SONSIK JOURNAL 3, 15-22, 2011 | | 2011 |
| Cloning, expression and comparison of cytochromes p450 from Streptomyces hygroscopicus NRRL3602 with its homologues K Rijal, HC Lee, JK Sohng J. Biomolecule Reconstruction 1, 9-24, 2004 | | 2004 |
Richard Maraia, M.D.NICHD, NIHVerified email at mail.nih.gov
